Unintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking Combined With GRAIL Galleri Testing to Improve Early Detection
Eligible age
40–80 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Unintentional weight loss (UWL) is commonly associated with a wide variety of diseases and there is still no valid diagnostic pathway for evaluating UWL. When detecting UWL coupled with GRAIL Galleri testing, (an investigational pan-cancer early detection test), it is thought that there is a greater positive predictive value in detecting malignancies. This study aims to test the potential synergistic effects of UWL detection and GRAIL usage to detect malignancy at an even earlier rate. UWL will be measured using weekly weight tracking.
Sponsor: Case Comprehensive Cancer Center
You may qualify if…
- ✓ Age range: from 40 to 80 years
- ✓ Access to a device (cellphone, computer, tablet) that is compatible with the Fitbit Aria Air smart scale utilized in this study
- ✓ Willing to comply with all study procedures and be available for the duration of the study
- ✓ Subjects must be mentally competent and must have the ability to understand and the willingness to sign a written informed consent document
- ✓ Subjects must speak English to maximize chance of understanding the trial rational and study procedures
You may not qualify if…
- ✕ Active cancer diagnosis - current diagnosis, currently undergoing cancer treatment, or concluded cancer treatments within 3 years
- ✕ Actively trying to lose weight with medications or bariatric surgery
- ✕ Pregnant
Where it's recruiting
Cleveland
Source: ClinicalTrials.gov · NCT05481697 · last updated 2026-06-12